For one of the world’s leading providers of insurance and retirement products, our team conducted a comprehensive analysis of the treatment costs for the most common diseases in Poland. The project also included an assessment of the costs of treating rare diseases, which for many patients involve very high, often unplanned expenses.

Project Objectives

The purpose of the study was to provide the client with reliable, up-to-date data on the costs of treating the diseases most likely to occur in Poland—from the patient’s perspective. The analysis was also intended to cover rare diseases, which generate exceptionally high costs for patients and their families. This information was essential for supporting the client’s business activities, including the preparation of a publicly available report as well as marketing and sales materials.

Project details:

Our team carried out the project using two main methods. We completed the following:

• Desk research – an analysis of available secondary sources, industry reports, and system data on reimbursed and non-reimbursed costs.
• Expert interviews—in-depth conversations with representatives of patient organizations and physicians—that provided unique, non-public information on the actual out-of-pocket expenses incurred by patients in Poland.

Thanks to our team’s many years of experience in the healthcare sector, the project was carried out smoothly and efficiently, despite the limited availability of open data on out-of-pocket medical costs.

Project Results

Based on our research, we’ve put together a checklist:

• A clear overview of healthcare costs in Poland—both those reimbursed by the National Health Fund (NFZ) and those paid directly by patients (e.g., medications, rehabilitation equipment, private visits, and procedures).
• An analysis of the costs of treating the most common diseases and selected rare diseases—broken down by cost type, treatment duration, and funding sources.
• Conclusions and recommendations from experienced analysts—practical guidance on the factors affecting costs and possible solutions to reduce the financial burden on patients.
• Report ready for publication—used by the client for both informational and marketing and sales purposes.

What did the customer gain?

The project enabled the client to:

• A better understanding of the actual costs of treatment from the patient’s perspective—key to designing insurance products and educational campaigns.
• Building a reputation as a market expert—by publishing a report and sharing knowledge with a broad group of stakeholders.
• Support for marketing and sales activities—by providing reliable data and analyses that build customer confidence in the products offered.

Summary

PMR’s analysis of the treatment costs for the most common diseases in Poland serves as a reliable tool for insurance companies and the healthcare industry, enabling them to make sound business decisions and effectively help patients prepare for unexpected healthcare expenses.

Share:

Need more data? At PMR, we advise and support your company's operations.

Need more data? At PMR, we advise and support your company's operations.

Marta Marszałek

Head Pharmaceutical & Healthcare Market Analyst

Let’s meet